Obesity and fetal-maternal outcomes
Angela Dinatale1, Santina Ermito, Ilenia Fonti
1Department of Obstetrics and Gynecology, Policlinico Universitario "G. Martino", Messina, Italia.
Journal of Prenatal Medicine
|March 23, 2012
Summary
Obesity significantly impacts female reproductive health, leading to infertility and numerous pregnancy complications. Obese pregnant women face higher risks for adverse obstetric outcomes, increasing maternal and neonatal morbidity and mortality.
Area of Science:
- Reproductive Endocrinology
- Maternal-Fetal Medicine
- Public Health
Background:
- Obesity is a prevalent global health issue.
- It significantly affects female reproductive function and pregnancy outcomes.
- Adverse obstetric outcomes are more common in obese women.
Purpose of the Study:
- To outline the multifaceted impact of obesity on female reproductive health.
- To detail the spectrum of pregnancy complications associated with obesity.
- To emphasize the high-risk nature of pregnancies in obese women.
Main Methods:
- Literature review of studies on obesity and reproductive health.
- Analysis of reported obstetric complications in obese pregnant populations.
- Correlation of obesity degree with complication rates.
Main Results:
- Obesity contributes to infertility and early pregnancy loss.
- Increased risks observed for pre-eclampsia, gestational diabetes, and congenital abnormalities.
- Higher rates of cesarean delivery, postpartum hemorrhage, and infection are noted.
Conclusions:
- Obesity poses substantial risks throughout female reproductive life and pregnancy.
- A linear increase in complication risk correlates with the degree of obesity.
- Obese pregnant women require careful management as a high-risk group.
More Related Videos
11:44A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta
Published on: September 27, 2017
14:40Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings
Published on: October 25, 2015
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...